Inhibition of human prolyl oligopeptidase activity by the Cyclotide Psysol 2 isolated from Psychotria solitudinum

dc.contributor.authorHellinger, Roland
dc.contributor.authorKoehbach, Johannes
dc.contributor.authorPuigpinós, Albert
dc.contributor.authorClark, Richard J.
dc.contributor.authorTarragó Clua, Maria Teresa
dc.contributor.authorGiralt Lledó, Ernest
dc.contributor.authorGruber, Christian W.
dc.date.accessioned2020-05-04T15:14:21Z
dc.date.available2020-05-04T15:14:21Z
dc.date.issued2015
dc.date.updated2020-05-04T15:14:21Z
dc.description.abstractCyclotides are head-to-tail cyclized peptides comprising a stabilizing cystine-knot motif. To date, they are well known for their diverse bioactivities such as anti-HIV and immunosuppressive properties. Yet little is known about specific molecular mechanisms, in particular the interaction of cyclotides with cellular protein targets. Native and synthetic cyclotide-like peptides from Momordica plants are potent and selective inhibitors of different serine-type proteinases such as trypsin, chymotrypsin, matriptase, and tryptase-beta. This study describes the bioactivity-guided isolation of a cyclotide from Psychotria solitudinum as an inhibitor of another serine-type protease, namely, the human prolyl oligopeptidase (POP). Analysis of the inhibitory potency of Psychotria extracts and subsequent fractionation by liquid chromatography yielded the isolated peptide psysol 2 (1), which exhibited an IC50 of 25 μM. In addition the prototypical cyclotide kalata B1 inhibited POP activity with an IC50 of 5.6 μM. The inhibitory activity appeared to be selective for POP, since neither psysol 2 nor kalata B1 were able to inhibit the proteolytic activity of trypsin or chymotrypsin. The enzyme POP is well known for its role in memory and learning processes, and it is currently being considered as a promising therapeutic target for the cognitive deficits associated with several psychiatric and neurodegenerative diseases, such as schizophrenia and Parkinson's disease. In the context of discovery and development of POP inhibitors with beneficial ADME properties, cyclotides may be suitable starting points considering their stability in biological fluids and possible oral bioavailability.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec652558
dc.identifier.issn0163-3864
dc.identifier.pmid25894999
dc.identifier.urihttps://hdl.handle.net/2445/158584
dc.language.isoeng
dc.publisherAmerican Chemical Society
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1021/np501061t
dc.relation.ispartofJournal of Natural Products, 2015, vol. 78, num. 5, p. 1073-1082
dc.relation.urihttps://doi.org/10.1021/np501061t
dc.rightscc-by (c) Hellinger, Rolland et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)
dc.subject.classificationPèptids
dc.subject.classificationMedicaments peptídics
dc.subject.otherPeptides
dc.subject.otherPeptide drugs
dc.titleInhibition of human prolyl oligopeptidase activity by the Cyclotide Psysol 2 isolated from Psychotria solitudinum
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
652558.pdf
Mida:
3.18 MB
Format:
Adobe Portable Document Format